Improved performance of first‐trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks
- 1 August 2008
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 28 (9) , 839-844
- https://doi.org/10.1002/pd.2057
Abstract
Objective To evaluate if there is a performance difference in the combined screening for trisomy 21 between the double tests performed before and after 10 + 0 weeks of gestation. Methods The study included all 97 trisomy 21 cases from January 2004 to December 2007, in a screening program where the double test was measured in week 8 + 0 to 13 + 6 and the nuchal translucency in week 11 + 3 to 13 + 6. Results As many as 87 of the 97 cases were diagnosed in the screening program (detection rate = 90%). Among the 53 cases having the double test taken before 10 + 0 weeks, no cases were missed [detection rate (DR) = 100%, CI = 0.94–1.00] and among the 44 having the double test taken after 10 + 0 weeks, 10 cases were missed (DR = 77%, CI = 0.65–0.90). This difference in DR was highly significant (P = 0.0009). No difference was observed between false positive rates or median maternal age of the two groups. Conclusion A significantly higher DR was obtained when the double test was taken early in pregnancy (<10 + 0 weeks), than when it was taken later (≥10 + 0 weeks). The results could not be explained by a difference in either the false positive rate or the maternal age between the two groups. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- First trimester screening for Down syndrome using free β hCG, total hCG and PAPP‐A: an exploratory studyPrenatal Diagnosis, 2007
- The “Consecutive Combined Test”—using Double test from week 8 + 0 and Nuchal Translucency Scan, for first trimester screening for Down SyndromePrenatal Diagnosis, 2006
- First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeNew England Journal of Medicine, 2005
- Prospective first-trimester screening for trisomy 21 in 30,564 pregnanciesAmerican Journal of Obstetrics and Gynecology, 2005
- Improved first‐trimester Down syndrome screening performance by lowering the false‐positive rate: a prospective study of 9941 low‐risk womenUltrasound in Obstetrics & Gynecology, 2005
- Multicenter study of first‐trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk‐orientated two‐stage first‐trimester screeningUltrasound in Obstetrics & Gynecology, 2005
- First‐trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional studyPrenatal Diagnosis, 2004
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experienceBJOG: An International Journal of Obstetrics and Gynaecology, 2003
- One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnanciesUltrasound in Obstetrics & Gynecology, 2002
- Combining Ultrasound and Biochemistry in First-Trimester Screening for Down's syndromePrenatal Diagnosis, 1997